Inherited lung cancer syndromes targeting never smokers
Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, pred...
Gespeichert in:
Veröffentlicht in: | Translational lung cancer research 2018-08, Vol.7 (4), p.498-504 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 504 |
---|---|
container_issue | 4 |
container_start_page | 498 |
container_title | Translational lung cancer research |
container_volume | 7 |
creator | Yamamoto, Hiromasa Yatabe, Yasushi Toyooka, Shinichi |
description | Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor (
) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline
T790M mutations had secondary
somatic mutations. Never smokers with germline
T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline
T790M mutations favored female gender. Therefore, germline
T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 (
). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline
G660D mutations. They had no
somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline
mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our
analyses, we administered
inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as
and
may have different features from those with sporadic mutations. |
doi_str_mv | 10.21037/tlcr.2018.06.01 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30225213</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMottTuXcn8gRnvTTJJZiNI8VEQ3Og6ZJJMOzqPkkwL_fd2rBZd3QOH71z4CLlGyCgCk7dDY0NGAVUGIgM8I1NKqUg5l_J8zKhSIXOckHmMHwCAvOB5XlySCQNKc4psSuSyW_tQD94lzbZbJdZ01ock7jsX-tbHZDBh5Yf6UHV-NzZt_-lDvCIXlWmin__cGXl_fHhbPKcvr0_Lxf1LarmgQ2pKlTthvKtcDkoKJ7yQ1imQXFYWjSrRUlEWonBKsIKjc8hz6RmrnABJ2YzcHXc327L1zvpuCKbRm1C3Jux1b2r9v-nqtV71Oy2QISo4DMBxwIY-xuCrE4ugvz3q0aMePWoQGvCA3Pz9eQJ-rbEvKltwcQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Inherited lung cancer syndromes targeting never smokers</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</creator><creatorcontrib>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</creatorcontrib><description>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor (
) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline
T790M mutations had secondary
somatic mutations. Never smokers with germline
T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline
T790M mutations favored female gender. Therefore, germline
T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 (
). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline
G660D mutations. They had no
somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline
mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our
analyses, we administered
inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as
and
may have different features from those with sporadic mutations.</description><identifier>ISSN: 2218-6751</identifier><identifier>EISSN: 2226-4477</identifier><identifier>DOI: 10.21037/tlcr.2018.06.01</identifier><identifier>PMID: 30225213</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Review</subject><ispartof>Translational lung cancer research, 2018-08, Vol.7 (4), p.498-504</ispartof><rights>2018 Translational Lung Cancer Research. All rights reserved. 2018 Translational Lung Cancer Research.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131180/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131180/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30225213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Yatabe, Yasushi</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><title>Inherited lung cancer syndromes targeting never smokers</title><title>Translational lung cancer research</title><addtitle>Transl Lung Cancer Res</addtitle><description>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor (
) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline
T790M mutations had secondary
somatic mutations. Never smokers with germline
T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline
T790M mutations favored female gender. Therefore, germline
T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 (
). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline
G660D mutations. They had no
somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline
mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our
analyses, we administered
inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as
and
may have different features from those with sporadic mutations.</description><subject>Review</subject><issn>2218-6751</issn><issn>2226-4477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMottTuXcn8gRnvTTJJZiNI8VEQ3Og6ZJJMOzqPkkwL_fd2rBZd3QOH71z4CLlGyCgCk7dDY0NGAVUGIgM8I1NKqUg5l_J8zKhSIXOckHmMHwCAvOB5XlySCQNKc4psSuSyW_tQD94lzbZbJdZ01ock7jsX-tbHZDBh5Yf6UHV-NzZt_-lDvCIXlWmin__cGXl_fHhbPKcvr0_Lxf1LarmgQ2pKlTthvKtcDkoKJ7yQ1imQXFYWjSrRUlEWonBKsIKjc8hz6RmrnABJ2YzcHXc327L1zvpuCKbRm1C3Jux1b2r9v-nqtV71Oy2QISo4DMBxwIY-xuCrE4ugvz3q0aMePWoQGvCA3Pz9eQJ-rbEvKltwcQ</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Yamamoto, Hiromasa</creator><creator>Yatabe, Yasushi</creator><creator>Toyooka, Shinichi</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180801</creationdate><title>Inherited lung cancer syndromes targeting never smokers</title><author>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Yatabe, Yasushi</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational lung cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Hiromasa</au><au>Yatabe, Yasushi</au><au>Toyooka, Shinichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inherited lung cancer syndromes targeting never smokers</atitle><jtitle>Translational lung cancer research</jtitle><addtitle>Transl Lung Cancer Res</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>7</volume><issue>4</issue><spage>498</spage><epage>504</epage><pages>498-504</pages><issn>2218-6751</issn><eissn>2226-4477</eissn><abstract>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor (
) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline
T790M mutations had secondary
somatic mutations. Never smokers with germline
T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline
T790M mutations favored female gender. Therefore, germline
T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 (
). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline
G660D mutations. They had no
somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline
mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our
analyses, we administered
inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as
and
may have different features from those with sporadic mutations.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>30225213</pmid><doi>10.21037/tlcr.2018.06.01</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2218-6751 |
ispartof | Translational lung cancer research, 2018-08, Vol.7 (4), p.498-504 |
issn | 2218-6751 2226-4477 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131180 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Review |
title | Inherited lung cancer syndromes targeting never smokers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inherited%20lung%20cancer%20syndromes%20targeting%20never%20smokers&rft.jtitle=Translational%20lung%20cancer%20research&rft.au=Yamamoto,%20Hiromasa&rft.date=2018-08-01&rft.volume=7&rft.issue=4&rft.spage=498&rft.epage=504&rft.pages=498-504&rft.issn=2218-6751&rft.eissn=2226-4477&rft_id=info:doi/10.21037/tlcr.2018.06.01&rft_dat=%3Cpubmed_cross%3E30225213%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30225213&rfr_iscdi=true |